Offer - Urjas Oil for just ₹ 1 X
Lorfast AM Syrup is a commercial drug that is prescribed in the form of Syrup. The alternative uses of Lorfast AM Syrup have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Lorfast AM Syrup. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Lorfast AM Syrup include Constipation, Heartburn, Nausea or vomiting. Apart from the aforementioned side effects, Lorfast AM Syrup can also lead to other problems, which have been listed below. Usually, these side effects of Lorfast AM Syrup go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Lorfast AM Syrup has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Lorfast AM Syrup has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lorfast AM Syrup related warnings section.
Individuals suffering from medical conditions like Gastrointestinal Bleeding must refrain from the use of Lorfast AM Syrup since this can cause severe adverse effects. The section on Lorfast AM Syrup contraindications lists all such conditions.
Additionally, Lorfast AM Syrup may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Lorfast AM Syrup is considered safe while driving, and is addictive.
Lorfast AM Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Lorfast AM Syrup safe for pregnant women?
Pregnant women may get severe side effects after taking Lorfast Am. If you are pregnant, do not take Lorfast Am without a doctor's advice.
Is the use of Lorfast AM Syrup safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Lorfast Am. It should only be taken after medical advice.
What is the effect of Lorfast AM Syrup on the Kidneys?
Lorfast Am has very mild side effects on the kidneys.
What is the effect of Lorfast AM Syrup on the Liver?
Lorfast Am is rarely harmful for the liver.
What is the effect of Lorfast AM Syrup on the Heart?
Lorfast Am is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Lorfast AM Syrup unless your doctor advises you to do so -
Is this Lorfast AM Syrup habit forming or addictive?
Forming a habit of Lorfast AM Syrup has not been reported.
Interaction between Food and Lorfast AM Syrup
Information is not available on the interaction of any foods with Lorfast AM Syrup, due to a lack of research on this.
Interaction between Alcohol and Lorfast AM Syrup
Information about the interaction of Lorfast AM Syrup and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Claritin® (loratadine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 790-791
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219